Key Findings:  The assay reliably confirmed the use of particular medical cannabis formulations in patient samples as well as reliably measured low CBD concentrations from single-dose CBD exposure.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Study Location(s):  United States
Year of Pub:  2019
Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabichromenic Acid (CBC-a), Cannabigerolic Acid (CBG-a), Tetrahydrocannabinolic Acid (THC-a), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source:  Not Applicable